Skip to main content
Top
Published in: BMC Psychiatry 1/2013

Open Access 01-12-2013 | Research article

Cognitive remediation improves cognition and good cognitive performance increases time to relapse – results of a 5 year catamnestic study in schizophrenia patients

Authors: Wolfgang Trapp, Michael Landgrebe, Katharina Hoesl, Stefan Lautenbacher, Bernd Gallhofer, Wilfried Günther, Goeran Hajak

Published in: BMC Psychiatry | Issue 1/2013

Login to get access

Abstract

Background

Cognitive deficits are stable features of schizophrenia that are linked to functional outcome. Cognitive remediation approaches have been proven successful in ameliorating these deficits, although effect sizes vary considerably. Whether cognitive deficits are serious predictors of clinical outcome is less clear.

Methods

Sixty patients suffering from schizophrenia were included in our sample, thirty of them received computer-assisted cognitive training, and thirty received occupational therapy. For a subsample of 55 patients, who could be traced over a period of five years after the end of the cognitive remediation intervention, time until first relapse and time in psychosis were determined retrospectively from their medical records.

Results

Cognitive remediation significantly improved problem solving, memory and attention with high effect sizes. Employment status, a post test verbal memory performance measure and a measure of executive functioning outperformed all other measures in the prediction of time to relapse, while allocation to treatment group outperformed all other variables in the prediction of both cognitive measures.

Conclusions

Cognitive remediation of neurocognitive deficits thus makes sense in a twofold fashion: It enhances cognition directly and positively acts on clinical course indirectly via improved neurocognition.

Trial registration

German Clinical Trials Register: DRKS00004880
Appendix
Available only for authorised users
Literature
1.
go back to reference Heinrichs RW, Zakzanis KK: Neurocognitive deficits in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998, 12: 426-445.CrossRefPubMed Heinrichs RW, Zakzanis KK: Neurocognitive deficits in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998, 12: 426-445.CrossRefPubMed
2.
go back to reference Aleman A, Hijman R, De Haan EHF, Kahn RS: Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999, 156: 1358-1366.PubMed Aleman A, Hijman R, De Haan EHF, Kahn RS: Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999, 156: 1358-1366.PubMed
3.
go back to reference Dickinson D, Ramsey ME, Gold JM: Overlooking the obvious: a meta-analytical comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007, 64: 532-542. 10.1001/archpsyc.64.5.532.CrossRefPubMed Dickinson D, Ramsey ME, Gold JM: Overlooking the obvious: a meta-analytical comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007, 64: 532-542. 10.1001/archpsyc.64.5.532.CrossRefPubMed
4.
go back to reference Cannon M, Caspi A, Moffitt TE, et al: Evidence for earlychildhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002, 59: 449-456. 10.1001/archpsyc.59.5.449.CrossRefPubMed Cannon M, Caspi A, Moffitt TE, et al: Evidence for earlychildhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002, 59: 449-456. 10.1001/archpsyc.59.5.449.CrossRefPubMed
5.
go back to reference Asarnow RF, Nuechterlein KH, Subotnik KL, Fogelson DL, Torquato RD, Payne DL, et al: Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attentiondeficit/hyperactivity disorder: The University of California, Los Angeles Family Study. Arch Gen Psychiatry. 2002, 59: 1053-1060. 10.1001/archpsyc.59.11.1053.CrossRefPubMed Asarnow RF, Nuechterlein KH, Subotnik KL, Fogelson DL, Torquato RD, Payne DL, et al: Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attentiondeficit/hyperactivity disorder: The University of California, Los Angeles Family Study. Arch Gen Psychiatry. 2002, 59: 1053-1060. 10.1001/archpsyc.59.11.1053.CrossRefPubMed
6.
go back to reference Nuechterlein KH, Asarnow RF, Subotnik KL, Fogelson DL, Payne DL, Kendler KS, et al: The structure of schizotypy: Relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophr Res. 2002, 54: 121-130. 10.1016/S0920-9964(01)00359-0.CrossRefPubMed Nuechterlein KH, Asarnow RF, Subotnik KL, Fogelson DL, Payne DL, Kendler KS, et al: The structure of schizotypy: Relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophr Res. 2002, 54: 121-130. 10.1016/S0920-9964(01)00359-0.CrossRefPubMed
7.
go back to reference Bora E, Yücel M: Pantelis C Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull. 2010, 36 (1): 36-42. 10.1093/schbul/sbp094.CrossRefPubMed Bora E, Yücel M: Pantelis C Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull. 2010, 36 (1): 36-42. 10.1093/schbul/sbp094.CrossRefPubMed
8.
go back to reference Keefe RSE, Fenton WS: How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr Bull. 2007, 33: 912-920. 10.1093/schbul/sbm046.CrossRefPubMedPubMedCentral Keefe RSE, Fenton WS: How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr Bull. 2007, 33: 912-920. 10.1093/schbul/sbm046.CrossRefPubMedPubMedCentral
9.
go back to reference Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996, 153: 321-330.CrossRefPubMed Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996, 153: 321-330.CrossRefPubMed
10.
go back to reference Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophr Bull. 2000, 26: 119-136. 10.1093/oxfordjournals.schbul.a033430.CrossRefPubMed Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?. Schizophr Bull. 2000, 26: 119-136. 10.1093/oxfordjournals.schbul.a033430.CrossRefPubMed
11.
go back to reference Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004, 72: 41-51. 10.1016/j.schres.2004.09.009.CrossRefPubMed Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004, 72: 41-51. 10.1016/j.schres.2004.09.009.CrossRefPubMed
12.
go back to reference Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L: The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011, 35 (3): 573-588. 10.1016/j.neubiorev.2010.07.001.CrossRefPubMed Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L: The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev. 2011, 35 (3): 573-588. 10.1016/j.neubiorev.2010.07.001.CrossRefPubMed
13.
go back to reference Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, et al: Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011, 37 (Suppl. 2): S33-S40.CrossRefPubMedPubMedCentral Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, et al: Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull. 2011, 37 (Suppl. 2): S33-S40.CrossRefPubMedPubMedCentral
14.
go back to reference Holthausen EAE, Wiersma D, Cahn W, Kahn RS, Dingemans PM, Schene AH, van den Bosch RJ: Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res. 2007, 149: 71-80. 10.1016/j.psychres.2005.07.037.CrossRefPubMed Holthausen EAE, Wiersma D, Cahn W, Kahn RS, Dingemans PM, Schene AH, van den Bosch RJ: Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res. 2007, 149: 71-80. 10.1016/j.psychres.2005.07.037.CrossRefPubMed
15.
go back to reference Moritz S, Krausz M, Gottwalz E, Lambert M, Perro C, Ganzer S, Naber D: Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics. Psychopathology. 2000, 33: 48-51. 10.1159/000029119.CrossRefPubMed Moritz S, Krausz M, Gottwalz E, Lambert M, Perro C, Ganzer S, Naber D: Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics. Psychopathology. 2000, 33: 48-51. 10.1159/000029119.CrossRefPubMed
16.
go back to reference Gråwe RW, Levander S: Neuropsychological impairments in patients with schizophrenia: stability and prediction of outcome. Acta Psychiatr Scand Suppl. 2001, 408: 60-64.CrossRefPubMed Gråwe RW, Levander S: Neuropsychological impairments in patients with schizophrenia: stability and prediction of outcome. Acta Psychiatr Scand Suppl. 2001, 408: 60-64.CrossRefPubMed
17.
go back to reference Wölwer W, Brinkmeyer J, Riesbeck M, Freimüller L, Klimke A, Wagner M, Möller HJ, Klingberg S, Gaebel W: German Study Group on First Episode Schizophrenia. Neuropsychological impairments predict the clinical course in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2008, 258 (Suppl 5): 28-34.CrossRefPubMed Wölwer W, Brinkmeyer J, Riesbeck M, Freimüller L, Klimke A, Wagner M, Möller HJ, Klingberg S, Gaebel W: German Study Group on First Episode Schizophrenia. Neuropsychological impairments predict the clinical course in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2008, 258 (Suppl 5): 28-34.CrossRefPubMed
18.
go back to reference Eberhard J, Levander S, Lindström E: Remission in schizophrenia: analysis in a naturalistic setting. Compr Psychiatry. 2009, 50 (3): 200-208. 10.1016/j.comppsych.2008.08.010.CrossRefPubMed Eberhard J, Levander S, Lindström E: Remission in schizophrenia: analysis in a naturalistic setting. Compr Psychiatry. 2009, 50 (3): 200-208. 10.1016/j.comppsych.2008.08.010.CrossRefPubMed
19.
go back to reference Robinson D, Woerner MG, Alvir JMJ, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response form a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999, 56: 241-247. 10.1001/archpsyc.56.3.241.CrossRefPubMed Robinson D, Woerner MG, Alvir JMJ, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response form a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999, 56: 241-247. 10.1001/archpsyc.56.3.241.CrossRefPubMed
20.
go back to reference Stirling J, White C, Lewis S, Hopkins R, Tantam D, Huddy A, Montague L: Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr Res. 2003, 65: 75-86. 10.1016/S0920-9964(03)00014-8.CrossRefPubMed Stirling J, White C, Lewis S, Hopkins R, Tantam D, Huddy A, Montague L: Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort. Schizophr Res. 2003, 65: 75-86. 10.1016/S0920-9964(03)00014-8.CrossRefPubMed
21.
go back to reference Buckley PF, Harvey PD, Bowie CR, Loebel A: The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr Res. 2007, 94: 99-106. 10.1016/j.schres.2006.12.032.CrossRefPubMed Buckley PF, Harvey PD, Bowie CR, Loebel A: The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone. Schizophr Res. 2007, 94: 99-106. 10.1016/j.schres.2006.12.032.CrossRefPubMed
22.
go back to reference Wykes T, Huddy V, Cellard C, McGurk S, Czobar P: A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011, 168: 472-485. 10.1176/appi.ajp.2010.10060855.CrossRefPubMed Wykes T, Huddy V, Cellard C, McGurk S, Czobar P: A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011, 168: 472-485. 10.1176/appi.ajp.2010.10060855.CrossRefPubMed
23.
go back to reference McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT: A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007, 164: 1791-1802. 10.1176/appi.ajp.2007.07060906.CrossRefPubMedPubMedCentral McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT: A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007, 164: 1791-1802. 10.1176/appi.ajp.2007.07060906.CrossRefPubMedPubMedCentral
24.
go back to reference Grynszpan O, Perbal S, Pelissolo A, Fossati P, Jouvent R, Dubal S, Perez-Diaz F: Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychol Med. 2011, 41 (1): 163-173. 10.1017/S0033291710000607.CrossRefPubMed Grynszpan O, Perbal S, Pelissolo A, Fossati P, Jouvent R, Dubal S, Perez-Diaz F: Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: a meta-analytical study. Psychol Med. 2011, 41 (1): 163-173. 10.1017/S0033291710000607.CrossRefPubMed
25.
go back to reference Wykes T, Spaulding WD: Thinking about the future cognitive remediation therapy–what works and could we do better?. Schizophr Bull. 2011, 37 (Suppl 2): S80-S90. 10.1093/schbul/sbr064.CrossRefPubMedPubMedCentral Wykes T, Spaulding WD: Thinking about the future cognitive remediation therapy–what works and could we do better?. Schizophr Bull. 2011, 37 (Suppl 2): S80-S90. 10.1093/schbul/sbr064.CrossRefPubMedPubMedCentral
26.
go back to reference Trapp W, Hasmann A, Gallhofer B, Schwerdtner J, Guenther W, Dobmeier M: Cognitive Improvement of Schizophrenia Patients: Enhancing Cognition while Enjoying Computer-Aided Cognitive Training. Clin Sch Rel Psych. 2008, 1 (4): 307-316. Trapp W, Hasmann A, Gallhofer B, Schwerdtner J, Guenther W, Dobmeier M: Cognitive Improvement of Schizophrenia Patients: Enhancing Cognition while Enjoying Computer-Aided Cognitive Training. Clin Sch Rel Psych. 2008, 1 (4): 307-316.
27.
go back to reference Trapp W: X-Cog user manual. 2003, Erlangen: Gruner Trapp W: X-Cog user manual. 2003, Erlangen: Gruner
28.
go back to reference First MB, Williams JB, Spitzer RL: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). 1997, Washington, D.C.: American Psychiatric Press, Inc First MB, Williams JB, Spitzer RL: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). 1997, Washington, D.C.: American Psychiatric Press, Inc
29.
go back to reference Andreasen NC: The Scale for the Assessment of Postivie Symptoms (SAPS) Iowa City. 1984, IA: The University of Iowa Andreasen NC: The Scale for the Assessment of Postivie Symptoms (SAPS) Iowa City. 1984, IA: The University of Iowa
30.
go back to reference Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS) Iowa City. 1984, IA: The University of Iowa Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS) Iowa City. 1984, IA: The University of Iowa
31.
go back to reference Zerssen D: Paranoid-Depressivitäts-Skala sowie Depressivitäts-Skala-Manual. 1976, Weinheim: Beltz, German Zerssen D: Paranoid-Depressivitäts-Skala sowie Depressivitäts-Skala-Manual. 1976, Weinheim: Beltz, German
32.
go back to reference Young DA, Freyslinger MG: Scaffolded instruction and the remediation of Wisconsin Card Sorting Test deficits in chronic schizophrenia. Schizophr Res. 1995, 16 (3): 199-207. 10.1016/0920-9964(94)00074-I.CrossRefPubMed Young DA, Freyslinger MG: Scaffolded instruction and the remediation of Wisconsin Card Sorting Test deficits in chronic schizophrenia. Schizophr Res. 1995, 16 (3): 199-207. 10.1016/0920-9964(94)00074-I.CrossRefPubMed
33.
go back to reference Wechsler D: Wechsler Memory Scale—Revised manual. 1987, San Antonio: The Psychological Corporation Wechsler D: Wechsler Memory Scale—Revised manual. 1987, San Antonio: The Psychological Corporation
34.
go back to reference Reitan RM: Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958, 8: 271-276.CrossRef Reitan RM: Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958, 8: 271-276.CrossRef
35.
go back to reference Nuechterlein KH, Parasuraman R, Jiang Q: Visual sustained attention: image degradation produces rapid sensitivity decrement over time. Science. 1983, 220: 327-329. 10.1126/science.6836276.CrossRefPubMed Nuechterlein KH, Parasuraman R, Jiang Q: Visual sustained attention: image degradation produces rapid sensitivity decrement over time. Science. 1983, 220: 327-329. 10.1126/science.6836276.CrossRefPubMed
36.
go back to reference Nuechterlein KH, Edell WS, Norris M, Dawson ME: Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull. 1986, 12: 408-426. 10.1093/schbul/12.3.408.CrossRefPubMed Nuechterlein KH, Edell WS, Norris M, Dawson ME: Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull. 1986, 12: 408-426. 10.1093/schbul/12.3.408.CrossRefPubMed
37.
go back to reference Rosner B: Fundamentals of Biostatistics. 2011, Boston, MA: Brooks/Cole, 7 Rosner B: Fundamentals of Biostatistics. 2011, Boston, MA: Brooks/Cole, 7
38.
go back to reference Lang U: Kognitive Defizite bei Schizophrenien. Evaluation des computergestützten kognitiven Trainings X-Cog. 2006, Regensburg: Roderer, German Lang U: Kognitive Defizite bei Schizophrenien. Evaluation des computergestützten kognitiven Trainings X-Cog. 2006, Regensburg: Roderer, German
39.
go back to reference Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD: Predicting schizophrenia patients’ real world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008, 63: 505-511. 10.1016/j.biopsych.2007.05.022.CrossRefPubMed Bowie CR, Leung WW, Reichenberg A, McClure MM, Patterson TL, Heaton RK, Harvey PD: Predicting schizophrenia patients’ real world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry. 2008, 63: 505-511. 10.1016/j.biopsych.2007.05.022.CrossRefPubMed
40.
go back to reference Milev P, Ho BC, Arndt S, Andreasen NC: Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005, 162: 495-506. 10.1176/appi.ajp.162.3.495.CrossRefPubMed Milev P, Ho BC, Arndt S, Andreasen NC: Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005, 162: 495-506. 10.1176/appi.ajp.162.3.495.CrossRefPubMed
41.
go back to reference Wittorf A, Wiedemann G, Buchkremer G, Klingberg S: Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosci. 2008, 258: 48-58. 10.1007/s00406-008-2004-3.CrossRefPubMed Wittorf A, Wiedemann G, Buchkremer G, Klingberg S: Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosci. 2008, 258: 48-58. 10.1007/s00406-008-2004-3.CrossRefPubMed
42.
go back to reference Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, Yung AR, Anderson VA, McGorry PD: Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry. 2005, 162: 71-78. 10.1176/appi.ajp.162.1.71.CrossRefPubMed Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, Yung AR, Anderson VA, McGorry PD: Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry. 2005, 162: 71-78. 10.1176/appi.ajp.162.1.71.CrossRefPubMed
43.
go back to reference Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, Cornblatt BA: Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2005, 59: 863-871.CrossRefPubMed Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, Cornblatt BA: Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2005, 59: 863-871.CrossRefPubMed
44.
go back to reference Whyte MC, Brett C, Harrison LK, Byrne M, Miller P, Lawrie SM, Johnstone EC: Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry. 2006, 59: 730-739. 10.1016/j.biopsych.2005.08.028.CrossRefPubMed Whyte MC, Brett C, Harrison LK, Byrne M, Miller P, Lawrie SM, Johnstone EC: Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry. 2006, 59: 730-739. 10.1016/j.biopsych.2005.08.028.CrossRefPubMed
45.
go back to reference Fowles D: Schizophrenia: diathesis-stress revisited. Annu Rev Psychol. 1992, 43: 303-336. 10.1146/annurev.ps.43.020192.001511.CrossRefPubMed Fowles D: Schizophrenia: diathesis-stress revisited. Annu Rev Psychol. 1992, 43: 303-336. 10.1146/annurev.ps.43.020192.001511.CrossRefPubMed
46.
go back to reference Nuechterlein KH, Dawson ME, Ventura J, et al: The vulnerability/ stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl. 1994, 382: 58-64.CrossRefPubMed Nuechterlein KH, Dawson ME, Ventura J, et al: The vulnerability/ stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl. 1994, 382: 58-64.CrossRefPubMed
47.
go back to reference Walker E, Diforio D: Schizophrenia: a neural diathesis-stress model. Psychol Rev. 1997, 104: 667-685.CrossRefPubMed Walker E, Diforio D: Schizophrenia: a neural diathesis-stress model. Psychol Rev. 1997, 104: 667-685.CrossRefPubMed
48.
go back to reference Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. NEngl J Med. 2005, 13 (12): 1209-1223.CrossRef Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. NEngl J Med. 2005, 13 (12): 1209-1223.CrossRef
49.
go back to reference Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE, EUFEST study group: Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008, 13 (9618): 1085-1097.CrossRef Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE, EUFEST study group: Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008, 13 (9618): 1085-1097.CrossRef
50.
go back to reference Alonso J, Croudace T, Brown J, Gasquet I, Knapp MR, Suárez D, Novick D: Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) study. Value Health. 2009, 12 (4): 536-543. 10.1111/j.1524-4733.2008.00495.x.CrossRefPubMed Alonso J, Croudace T, Brown J, Gasquet I, Knapp MR, Suárez D, Novick D: Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) study. Value Health. 2009, 12 (4): 536-543. 10.1111/j.1524-4733.2008.00495.x.CrossRefPubMed
Metadata
Title
Cognitive remediation improves cognition and good cognitive performance increases time to relapse – results of a 5 year catamnestic study in schizophrenia patients
Authors
Wolfgang Trapp
Michael Landgrebe
Katharina Hoesl
Stefan Lautenbacher
Bernd Gallhofer
Wilfried Günther
Goeran Hajak
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2013
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-13-184

Other articles of this Issue 1/2013

BMC Psychiatry 1/2013 Go to the issue